Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$52.9M |
| 2 |
CVS Health
CVS
|
+$49.8M |
| 3 |
Booking.com
BKNG
|
+$46.8M |
| 4 |
Philip Morris
PM
|
+$42.5M |
| 5 |
Abbott
ABT
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hewlett Packard
HPE
|
+$82M |
| 2 |
Sysco
SYY
|
+$54.1M |
| 3 |
Marriott International
MAR
|
+$50.1M |
| 4 |
Automatic Data Processing
ADP
|
+$49.8M |
| 5 |
Walt Disney
DIS
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.86% |
| 2 | Technology | 19.39% |
| 3 | Healthcare | 17.75% |
| 4 | Consumer Discretionary | 16.26% |
| 5 | Consumer Staples | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALY
401
Callaway Golf Company
CALY
$2.84B
| $4.46M | 0.06% |
406,540
+343,944
| +549% | +$3.9M |
|
402
Regeneron Pharmaceuticals
REGN
$85.9B
| $4.44M | 0.06% |
12,096
-12,649
| -51% | -$4.81M |
|
403
RPM International
RPM
$13.9B
| $4.43M | 0.06% |
82,394
-122,167
| -60% | -$6.25M |
|
404
Integer Holdings
ITGR
$4.26B
| $4.42M | 0.06% |
150,062
+87,977
| +142% | +$2.21M |
|
405
UnitedHealth
UNH
$350B
| $4.4M | 0.06% |
27,498
+154
| +0.6% | +$23K |
|
|
KND
406
DELISTED
Kindred Healthcare
KND
| $4.36M | 0.06% |
555,117
+186,989
| +51% | +$1.53M |
|
|
FINL
407
DELISTED
Finish Line
FINL
| $4.2M | 0.05% |
223,085
+111,462
| +100% | +$2.43M |
|
|
WRK
408
DELISTED
WestRock Company
WRK
| $4.16M | 0.05% |
82,018
-542,333
| -87% | -$26.7M |
|
409
Macy's
M
$6B
| $4.09M | 0.05% |
114,284
-291,868
| -72% | -$11.4M |
|
410
Buckle
BKE
$2.26B
| $4.09M | 0.05% |
179,243
-13,845
| -7% | -$318K |
|
411
Elevance Health
ELV
$86.9B
| $4.08M | 0.05% |
28,408
+9,104
| +47% | +$1.22M |
|
|
HA
412
DELISTED
Hawaiian Holdings, Inc.
HA
| $4.04M | 0.05% |
70,840
-117,402
| -62% | -$5.99M |
|
413
Aecom
ACM
$8.34B
| $4.03M | 0.05% |
110,692
+98,809
| +832% | +$3.28M |
|
414
Repligen
RGEN
$10.2B
| $3.99M | 0.05% |
129,559
-10,957
| -8% | -$339K |
|
415
Globus Medical
GMED
$11.7B
| $3.9M | 0.05% |
157,283
-574,895
| -79% | -$13.1M |
|
416
Graham Holdings Company
GHC
$4.94B
| $3.9M | 0.05% |
7,617
-8,503
| -53% | -$4.14M |
|
417
Euronet Worldwide
EEFT
$2.62B
| $3.88M | 0.05% |
+53,584
| New | +$4.14M |
|
|
RRD
418
DELISTED
RR Donnelley & Sons Co.
RRD
| $3.87M | 0.05% |
236,823
+230,577
| +3,692% | +$4.14M |
|
419
Meta Platforms (Facebook)
META
$1.4T
| $3.86M | 0.05% |
33,579
+27,078
| +417% | +$3.33M |
|
420
Matthews International
MATW
$664M
| $3.82M | 0.05% |
49,724
+31,126
| +167% | +$2.09M |
|
421
Steris
STE
$23.2B
| $3.8M | 0.05% |
56,454
-5,071
| -8% | -$344K |
|
422
Campbell Soup
CPB
$7.14B
| $3.79M | 0.05% |
62,763
-418,332
| -87% | -$23.4M |
|
|
AVX
423
DELISTED
AVX Corporation
AVX
| $3.79M | 0.05% |
242,338
-35,760
| -13% | -$527K |
|
424
Enviri
NVRI
$582M
| $3.77M | 0.05% |
277,009
+198,466
| +253% | +$2.38M |
|
|
ELNK
425
DELISTED
EarthLink Holdings Corp.
ELNK
| $3.76M | 0.05% |
666,067
-61,778
| -8% | -$352K |
|
Similar funds
Joel Greenblatt's Q4 2016 Portfolio in Review
As of Q4 2016, Joel Greenblatt held 1,149 positions worth $7.77B, up 1.2% from $7.68B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Joel Greenblatt withdrew a net $270M in Q4 2016, closing 225 positions and reducing 377 holdings. Its most notable exit was Sysco, an estimated $54.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Philip Morris worth $42M.
- Joel Greenblatt's largest Q4 2016 buy was Philip Morris: 458,877 shares worth $42M.
- Joel Greenblatt added most to Trane Technologies in Q4 2016, an estimated $52.9M increase.
- Joel Greenblatt's biggest Q4 2016 reduction was Hewlett Packard, cutting an estimated $82M.
- Joel Greenblatt fully exited Sysco in Q4 2016, selling an estimated $54.1M.
- Joel Greenblatt's ten largest holdings make up 8.9% of its $7.77B portfolio in Q4 2016.
- Joel Greenblatt opened 238 new positions and closed 225 in Q4 2016.
- Joel Greenblatt's portfolio value rose 1.2% quarter-over-quarter to $7.77B.
Based on Gotham Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.